General Information of Drug Inactive Ingredient (DIG) (ID: E00142)

DIG Name
Butylparaben
Synonyms
BUTYLPARABEN; Butyl 4-hydroxybenzoate; 94-26-8; Butyl paraben; Butyl p-hydroxybenzoate; Nipabutyl; Butoben; Butyl chemosept; Butyl parasept; Tegosept B; Butyl tegosept; Butyl butex; Tegosept Butyl; Aseptoform butyl; Preserval B; Butyl parahydroxybenzoate; Solbrol B; n-Butyl p-hydroxybenzoate; Butyl-Parasept; 4-(Butoxycarbonyl)phenol; Benzoic acid, 4-hydroxy-, butyl ester; n-Butyl parahydroxybenzoate; 4-Hydroxybenzoic acid butyl ester; n-Butyl hydroxybenzoate; n-Butyl-p-hydroxybenzoate; n-butyl 4-hydroxybenzoate; Benzoic acid, p-hydroxy-, butyl ester; n-Butyl-paraben; p-Hydroxybenzoic acid butyl ester; Lexgard B; n-Butyl-4-hydroxybenzoate; UNII-3QPI1U3FV8; NSC 8475; Butylparaben (NF); Butylparaben (TN); Butylparaben [NF]; SPF; p-Hydroxybenzoic acid, butyl ester; 4-Hydroxybenzoic acid, butyl ester; MFCD00016478; p-Hydroxybenzoic butyl ester; 3QPI1U3FV8; Butyl parahydroxybenzoate (TN); CHEBI:88542; CAS-94-26-8; NCGC00016354-03; DSSTox_CID_209; DSSTox_RID_75434; DSSTox_GSID_20209; F0266-0124; Butylparaben [USAN]; Butyl 4-hydroxybenzoate, 99+%; butyl-p-hydroxybenzoate; Caswell No. 130A; FEMA Number 2203; n-Butyl paraben; Butyl Par asept; SMR000462402; FEMA No. 2203; CCRIS 2462; HSDB 286; butyl p-hydroxy benzoate; p-Hydroxy butyl benzoate; SR-01000389296; p-Hydroxybenzoic acid n-butyl ester; EINECS 202-318-7; EPA Pesticide Chemical Code 061205; BRN 1103741; butyl-paraben; AI3-02930; 27K; Butyl Paraben-[d9]; 4mg9; Prestwick0_000894; Prestwick1_000894; Prestwick2_000894; Prestwick3_000894; ACMC-209rr1; WLN: QR DVO4; cid_7184; SCHEMBL3647; BSPBio_000708; Butyl //p//-Hydroxybenzoate; MLS000575004; MLS002154054; MLS002303045; BIDD:ER0231; SPBio_002917; BPBio1_000780; CHEMBL459008; N-Butyl-P-Hydroxybenzoate,(S); DTXSID3020209; BDBM23448; FEMA 2203; NSC8475; Butyl parahydroxybenzoate (JP15); Butyl parahydroxybenzoate (JP17); Butyl 4-hydroxybenzoate, >=99%; BUTYL PARA HYDROXY BENZOATE; HMS1570D10; HMS2094A21; HMS2097D10; HMS2220G15; HMS3327P04; HMS3714D10; Pharmakon1600-01505995; HY-B1431; NSC-8475; ZINC1586769; 4-Hydroxybenzoic acid-n-butyl ester; Tox21_110393; Tox21_201785; Tox21_300332; ANW-40235; NSC759303; p-Hydroxybenzoic acid, n-butyl ester; s4584; SBB060338; AKOS000121421; Tox21_110393_1; CCG-213596; CS-4783; DB14084; MCULE-3352613586; MP-2138; NSC-759303; Butyl 4-?Hydroxybenzoate(Butyl Paraben); NCGC00016354-01; NCGC00016354-02; NCGC00016354-04; NCGC00016354-05; NCGC00016354-06; NCGC00016354-07; NCGC00016354-11; NCGC00091142-01; NCGC00091142-02; NCGC00254294-01; NCGC00259334-01; AK113821; AS-14309; K716; SBI-0206946.P001; Butyl 4-hydroxybenzoate, >=99.0% (GC); DS-010619; AB00513951; B3771; FT-0623315; ST50405535; A16382; D01420; AB00513951_09; Q3302873; SR-01000389296-1; SR-01000389296-3; W-100204; BRD-K08287586-001-03-6; BRD-K08287586-001-08-5; Butyl 4-hydroxybenzoate, SAJ first grade, >=99.0%; Z291799028; 4-Hydroxybenzoic acid-n-butyl ester 1000 microg/mL in Acetonitrile
DIG Function
Antimicrobial preservative
Formula
C11H14O3
Canonical SMILES
CCCCOC(=O)C1=CC=C(C=C1)O
InChI
1S/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H3
InChIKey
QFOHBWFCKVYLES-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 194.23 Topological Polar Surface Area 46.5
XlogP 3.6 Complexity 171
Heavy Atom Count 14 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

20 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Allergic rhinitis [CA08.0] Acetaminophen 500 mg tablet F00390
Ceftibuten DMWV2AG Acute otitis media [AB00] Ceftibuten 400 mg capsule F03680
Chlordiazepoxide DMTN5XI Alcohol withdrawal [] Chlordiazepoxide 10 mg capsule F03980
Cycloserine DMT1I52 Bacterial infection [1A00-1C4Z] Cycloserine 250 mg capsule F05160
Diphenhydramine DMKQTBA Hyperemesis gravidarum [] Diphenhydramine 25 mg capsule F06256
Ergocalciferol DMHO0AR Hypoparathyroidism [5A50] Ergocalciferol 50000 unt capsule F07340
Flucytosine DM13VTW Cryptococcal meningitis [] Flucytosine 250 mg capsule F08398
Fluoxetine DM3PD2C Bipolar depression [] Fluoxetine 20 mg capsule F08473
Fluvastatin DM4MDJY Arteriosclerosis [BD40] Fluvastatin 20 mg capsule F08582
Gentamicin DMKINJO Bacteremia [1A73] Gentamicin 0.1% ointment F23760
Halobetasol Propionate DM3GB6S Inflammation [1A00-CA43.1] Halobetasol Propionate 0.05% lotion F23768
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia [2A20.0] Hydroxyurea 500 mg capsule F09899
Loxapine DM8AI9U Bipolar disorder [6A60] Loxapine 10 mg capsule F12660
Nortriptyline DM4KDYJ Depression [6A70-6A7Z] Nortriptyline 10 mg capsule F15511
Oxazepam DMXNZM4 Alcohol withdrawal delirium [] Oxazepam 10 mg capsule F16094
Phenytoin DMNOKBV Epilepsy [8A60-8A68] Phenytoin 100 mg capsule F17220
Ranitidine DM0GUSX Gastric ulcer [DA60] Ranitidine Hydrochloride eq 15 mg base/mL syrup F23533
Temazepam DM02A65 Insomnia [7A00-7A0Z] Temazepam 15 mg capsule F20761
Tetracycline DMZA017 Acne vulgaris [ED80] Tetracycline 250 mg capsule F21016
Trimipramine DM1SC8M Major depressive disorder [6A70.3] Trimipramine 50 mg capsule F21721
------------------
⏷ Show the Full List of 20 Approved Drug(s)